TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Infectious Disease Diagnostics Market – By Product
1.3.2 North America Infectious Disease Diagnostics Market – By Technology
1.3.3 North America Infectious Disease Diagnostics Market – By Testing Type
1.3.4 North America Infectious Disease Diagnostics Market – By Disease Indication
1.3.5 North America Infectious Disease Diagnostics Market – By End User
1.3.6 North America Infectious Disease Diagnostics Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Infectious Disease Diagnostics Market Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Infectious Disease Diagnostics Market Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Prevalence of Infectious Diseases
5.1.2 Increasing Focus on R&D and Funding in Infectious Disease Diagnostics
5.2 Market Restraints
5.2.1 Inadequate Reimbursement Scenario
5.3 Market Opportunities
5.3.1 Growing Opportunities in Developing Nations
5.4 Future Trend
5.4.1 Rising Number of Product Approvals and Launches
5.5 Impact Analysis
6. Infectious Disease Diagnostics Market– North America Analysis
6.1 North America Infectious Disease Diagnostics Market Revenue Forecast and Analysis
7. North America Infectious Disease Diagnostics Market Revenue and Forecast To 2028– by Product
7.1 Overview
7.2 North America by Product: Market Revenue and Forecast Analysis (US$ Million)
7.3 Kits and Reagents
7.3.1 Overview
7.3.2 Kits and Reagents Market Revenue and Forecast to 2028 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments Market Revenue and Forecast to 2028 (US$ Million)
7.5 Software and Services
7.5.1 Overview
7.5.2 Software and Services Market Revenue and Forecast to 2028 (US$ Million)
8. North America Infectious Disease Diagnostics Market Analysis and Forecast to 2028 – by Technology
8.1 North America Infectious Disease Diagnostics Market Revenue Share, by Technology (2021 and 2028)
8.2 Immunodiagnostics
8.2.1 Overview
8.2.2 Immunodiagnostics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Polymerase Chain Reaction (PCR)
8.3.1 Overview
8.3.2 PCR: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Next Generation Sequencing
8.4.1 Overview
8.4.2 Next Generation Sequencing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Clinical Microbiology
8.5.1 Overview
8.5.2 Clinical Microbiology: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Infectious Disease Diagnostics Market Analysis and Forecast to 2028 – by Testing Type
9.1 North America Infectious Disease Diagnostics Market Revenue Share, by Testing Type (2021 and 2028)
9.2 Laboratory Testing
9.2.1 Overview
9.2.2 Laboratory Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Point of Care Testing
9.3.1 Overview
9.3.2 Point-of-Care Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Infectious Disease Diagnostics Market Analysis and Forecast to 2028 – by Disease Indication
10.1 Overview
10.2 North America Infectious Disease Diagnostics Market Revenue Share, by Disease Indication (2021 and 2028)
10.3 HIV
10.3.1 Overview
10.3.2 HIV Market Revenue and Forecast to 2028 (US$ Million)
10.4 Hepatitis
10.4.1 Overview
10.4.2 Hepatitis Market Revenue and Forecast to 2028 (US$ Million)
10.5 Healthcare Associated Infections (HAIs)
10.5.1 Overview
10.5.2 Hospital Associated Infections (HAIs) Market Revenue and Forecast to 2028 (US$ Million)
10.6 Human Papillomavirus (HPV)
10.6.1 Overview
10.6.2 Human Papillomavirus (HPV) Market Revenue and Forecast to 2028 (US$ Million)
10.7 Tuberculosis (TB)
10.7.1 Overview
10.7.2 Tuberculosis (TB) Market Revenue and Forecast to 2028 (US$ Million)
10.8 Influenza
10.8.1 Overview
10.8.2 Influenza Market Revenue and Forecast to 2028 (US$ Million)
10.9 Others
10.9.1 Overview
10.9.2 Others Market Revenue and Forecast to 2028 (US$ Million)
11. North America Infectious Disease Diagnostics Market Analysis – by End User
11.1 Overview
11.2 North America Infectious Disease Diagnostics Market Revenue Share, by End User (2021 and 2028)
11.3 Hospitals and Clinics
11.3.1 Overview
11.3.2 Hospitals and Clinics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
11.4 Pathology or Diagnostic Laboratories
11.4.1 Overview
11.4.2 Pathology or Diagnostics Laboratories: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
11.5 Research Institutes
11.5.1 Overview
11.5.2 Research Institutes: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
11.6 Home Care Settings
11.6.1 Overview
11.6.2 Home Care Settings: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
11.7 Others
11.7.1 Overview
11.7.2 Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12. North America Infectious Disease Diagnostics Market Revenue and Forecast to 2028 – Country Analysis
12.1 North America: Infectious Disease Diagnostics Market
12.1.1 Overview
12.1.3 North America: Infectious Disease Diagnostics Market, by Country, 2021 & 2028 (%)
12.1.3.1 US: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12.1.3.1.1 US: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12.1.3.1.2 US: Infectious Disease Diagnostics Market, by Product, 2019–2028 (US$ Million)
12.1.3.1.3 US: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (US$ Million)
12.1.3.1.4 US: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (US$ Million)
12.1.3.1.5 US: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (US$ Million)
12.1.3.1.6 US: Infectious Disease Diagnostics Market, by End User, 2019–2028 (US$ Million)
12.1.3.2 Canada: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12.1.3.2.1 Canada: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12.1.3.2.2 Canada: Infectious Disease Diagnostics Market, by Product, 2019–2028 (US$ Million)
12.1.3.2.3 Canada: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (US$ Million)
12.1.3.2.4 Canada: Infectious Disease Diagnostics Market, by Testing Type , 2019–2028 (US$ Million)
12.1.3.2.5 Canada: Infectious Disease Diagnostics Market, by Disease Indication , 2019–2028 (US$ Million)
12.1.3.2.6 Canada: Infectious Disease Diagnostics Market, by End User , 2019–2028 (US$ Million)
12.1.3.3 Mexico: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12.1.3.3.1 Mexico: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12.1.3.3.2 Mexico: Infectious Disease Diagnostics Market, by Product, 2019–2028 (US$ Million)
12.1.3.3.3 Mexico: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (US$ Million)
12.1.3.3.4 Mexico: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (US$ Million)
12.1.3.3.5 Mexico: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (US$ Million)
12.1.3.3.6 Mexico: Infectious Disease Diagnostics Market, by End User, 2019–2028 (US$ Million)
13. Industry Landscape
13.1 Overview
13.2 Organic Developments
13.2.1 Overview
13.3 Inorganic Developments
13.3.1 Overview
14. Company Profiles
14.1 Danaher
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Abbott
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 BD
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Trinity Biotech
14.4.1 1.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 F. HOFFMANN-LA ROCHE LTD.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Cardinal Health Inc.
14.6.1 1.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 bioMerieux SA
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 BIO-RAD LABORATORIES INC.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 AccuBioTech Co., Ltd.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 ACON Laboratories, Inc.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
LIST OF TABLES.
Table 1. North America Infectious Disease Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
Table 2. US Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 3. US Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 4. US Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 5. US Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Organic Developments Done By Companies
Table 18. Inorganic Developments Done By Companies
Table 19. Glossary of Terms